1. Home
  2. DRUG vs STRT Comparison

DRUG vs STRT Comparison

Compare DRUG & STRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • STRT
  • Stock Information
  • Founded
  • DRUG 2019
  • STRT 1908
  • Country
  • DRUG United States
  • STRT United States
  • Employees
  • DRUG N/A
  • STRT N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • STRT Auto Parts:O.E.M.
  • Sector
  • DRUG Health Care
  • STRT Consumer Discretionary
  • Exchange
  • DRUG Nasdaq
  • STRT Nasdaq
  • Market Cap
  • DRUG 210.7M
  • STRT 169.1M
  • IPO Year
  • DRUG N/A
  • STRT 1995
  • Fundamental
  • Price
  • DRUG $32.38
  • STRT $41.67
  • Analyst Decision
  • DRUG
  • STRT
  • Analyst Count
  • DRUG 0
  • STRT 0
  • Target Price
  • DRUG N/A
  • STRT N/A
  • AVG Volume (30 Days)
  • DRUG 382.4K
  • STRT 18.0K
  • Earning Date
  • DRUG 11-26-2024
  • STRT 11-04-2024
  • Dividend Yield
  • DRUG N/A
  • STRT N/A
  • EPS Growth
  • DRUG N/A
  • STRT N/A
  • EPS
  • DRUG N/A
  • STRT 3.94
  • Revenue
  • DRUG N/A
  • STRT $541,412,000.00
  • Revenue This Year
  • DRUG N/A
  • STRT $1.94
  • Revenue Next Year
  • DRUG N/A
  • STRT $4.24
  • P/E Ratio
  • DRUG N/A
  • STRT $10.57
  • Revenue Growth
  • DRUG N/A
  • STRT 6.58
  • 52 Week Low
  • DRUG $0.93
  • STRT $20.87
  • 52 Week High
  • DRUG $79.02
  • STRT $43.15
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 43.69
  • STRT 59.28
  • Support Level
  • DRUG $36.02
  • STRT $39.37
  • Resistance Level
  • DRUG $44.70
  • STRT $41.67
  • Average True Range (ATR)
  • DRUG 5.79
  • STRT 1.86
  • MACD
  • DRUG -3.22
  • STRT 0.10
  • Stochastic Oscillator
  • DRUG 6.26
  • STRT 90.35

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

Share on Social Networks: